| Literature DB >> 34848997 |
Jixin Chen1,2, Aifeng Liu1,2, Qinxin Zhou1,2, Weijie Yu1,2, Tianci Guo1,2, Yizhen Jia1,2, Kun Yang1,2, Puyu Niu1,2, Huichuan Feng1,2.
Abstract
BACKGROUND: Acupuncture has been widely used in the clinical management of osteoarthritis of the knee (KOA). Many systematic reviews (SRs) and meta-analyses (MAs) have reported its effectiveness in relieving pain. This overview aimed to summarize SRs and MAs on the effectiveness and safety of acupuncture for KOA and evaluate their methodological and evidence quality of the included SRs and MAs.Entities:
Keywords: AMSTAR 2; GRADE; acupuncture; knee osteoarthritis; overview; systematic review
Year: 2021 PMID: 34848997 PMCID: PMC8617312 DOI: 10.2147/IJGM.S342435
Source DB: PubMed Journal: Int J Gen Med ISSN: 1178-7074
Figure 1Flowchart of the selection process of included SRs and MAs.
Characteristics and Categorization of the Included Reviews
| Author (Year)Ref | Country | Number of RCT (Total Population) | Intervention | Outcome Measures | Quality Assessment Tool | Overall Conclusion | |
|---|---|---|---|---|---|---|---|
| Treatment Group | Control Group | ||||||
| Chai (2009) | China | 6 (n = 500) | AT, WA, EA | WM | Apparent rate, WOMAC score | Jadad score | Acupuncture is more effective than western medicine in the treatment of KOA. Acupuncture has fewer adverse effects. |
| Cao (2012) | China | 10 (n = 2289) | AT, EA | Sham AT, CC, Placebo, PT | WOMAC score | Cochrane risk of bias tool | Acupuncture provided significantly better relief from knee osteoarthritis pain and a larger improvement in function than sham acupuncture, standard care treatment, and waiting for further treatment. |
| Lu (2012) | China | 10 (n = 991) | WA, EA | WM | Total effective rate | Jadad score | Acupuncture is more effective than western medicine in the treatment of KOA. |
| Lu (2015) | China | 8 (n = 811) | WA | WM | Total effective rate, total forward effective rate, short-term cure rate, adverse effects, HSS functional score | Jadad score | Warm acupuncture for KOA is more effective and safer than conventional western medication. |
| Lin (2016) | China | 10 (n = 2007) | AT | Sham AT, CC, NA | WOMAC score | Cochrane risk of bias tool | Acupuncture can improve short and long-term physical function, but |
| Zhao (2016) | China | 13 (n = 1291) | EA | WM, HM | Effective rate, adverse effects | Cochrane risk of bias tool | The efficacy of electroacupuncture in the treatment of KOA is significantly better than that the medication. Electroacupuncture has fewer adverse effects. |
| Hu (2016) | China | 8 (n = 945) | AT, WA | WM | Total effective rate, WOMAC score | Cochrane risk of bias tool | Acupuncture is effective in the treatment of osteoarthritis of the knee. |
| Guo (2018) | China | 11 (n = 930) | WA | WM, HM | Total effective rate, WOMAC score | Cochrane risk of bias tool | Warm acupuncture is effective in the treatment of KOA and is more effective than oral Western medicine alone. |
| Cao (2019) | China | 9 (n = 786) | AT/WA+HA injection | HA injection | Short-term effective rate | Cochrane risk of bias tool | The recent clinical efficacy of acupuncture combined with sodium glacial injection for the treatment of KOA is better than that of sodium glacial injection alone. |
| Kong (2019) | China | 21 (n = 1810) | WA+HA injection | HA injection | Effective rate, VAS score, WOMAC score, Lysholm knee score | Cochrane risk of bias tool | The combination of warm acupuncture and sodium vitreous acid injection for the treatment of KOA has shown significant efficacy in reducing pain and improving knee function. |
| Zheng (2020) | China | 10 (n = 998) | AT/WA+HA injection | HA injection | Effective rate, VAS score, Lysholm knee score | Cochrane risk of bias tool | Current evidence suggests that acupuncture therapy combined with hyaluronic acid injection is more effective in alleviating pain, improving the ER and knee function compared with hyaluronic acid injection alone. |
| Wang (2020) | China | 18 (n = 3552) | AT/EA + MT, AT/EA + PT | Sham AT, NA, PT, HE | WOMAC score | Cochrane risk of bias tool | Acupuncture group had significant advantages over sham acupuncture or no-acupuncture groups in relieving pain and improving physical function. |
| Fan (2020) | China | 19 (n = 1426) | AT/WA +MT, AT + HA injection | WM | Total effective rate, WOMAC score, VAS score, Lysholm knee score, adverse effects | Cochrane risk of bias tool | Acupuncture has significant advantages in the treatment of KOA. |
| Yang (2021) | China | 10 (n = 744) | FA, FA + AT, FA + MT | WM | Total effective rate, cure rate, JOA score, adverse effects | Jadad score | Fire needle acupuncture may be more effective and safer than conventional western medicine in the treatment of KOA. |
Abbreviations: AT, acupuncture therapy; WA, warm acupuncture; EA, electroacupuncture; FA, fire needle acupuncture; NA, no acupuncture; HA, hyaluronic acid; MT, medicine therapy; PT, physical therapy; CC, conventional care; HE, health education; WM, western medicine pharmacological treatment; HM, herbal medicine; WOMAC, Western Ontario and Mcmaster Universities Arthritis Index; VAS, Visual Analog Scale; JOA, Japanese Orthopaedic Association.
Critical Appraisal of Studies Included, Through Using the AMSTAR 2 Tool
| Author (year) | AMSTAR 2 | Overall Quality | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Q1 | Q2 | Q3 | Q4 | Q5 | Q6 | Q7 | Q8 | Q9 | Q10 | Q11 | Q12 | Q13 | Q14 | Q15 | Q16 | ||
| Chai (2009) | Y | N | N | PY | N | N | N | PY | PY | N | Y | N | N | Y | N | N | Critically low |
| Cao (2012) | Y | N | N | PY | Y | Y | N | PY | Y | N | Y | Y | N | Y | N | N | Critically low |
| Lu (2012) | Y | N | N | PY | Y | N | N | PY | PY | N | Y | N | N | Y | Y | N | Critically low |
| Lu (2015) | Y | N | N | PY | N | N | N | PY | PY | N | N | N | N | N | Y | N | Critically low |
| Lin (2016) | Y | N | N | PY | Y | N | N | PY | Y | N | Y | Y | N | N | N | Y | Critically low |
| Zhao (2016) | Y | N | N | PY | N | Y | N | PY | Y | N | Y | Y | Y | Y | N | N | Critically low |
| Hu (2016) | Y | N | N | PY | N | N | N | PY | PY | N | Y | Y | Y | Y | N | N | Critically low |
| Guo (2018) | Y | N | N | PY | Y | Y | N | PY | Y | N | N | N | N | N | Y | N | Critically low |
| Cao (2019) | N | N | N | PY | Y | Y | N | PY | Y | N | N | Y | N | N | Y | N | Critically low |
| Kong (2019) | Y | N | N | PY | Y | Y | N | PY | Y | N | N | Y | N | N | Y | N | Critically low |
| Zheng (2020) | Y | N | N | PY | Y | Y | N | PY | Y | N | Y | Y | Y | Y | N | N | Critically low |
| Wang (2020) | Y | N | N | PY | Y | Y | N | PY | Y | N | Y | Y | Y | Y | Y | Y | Critically low |
| Fan (2020) | Y | N | N | PY | N | Y | N | PY | Y | N | Y | Y | Y | Y | Y | N | Critically low |
| Yang (2021) | Y | N | N | PY | Y | N | N | PY | PY | N | Y | Y | Y | Y | Y | N | Critically low |
| Number | 13(92.9) | 0(0) | 0(0) | 0(0) | 9(64.3) | 9(64.3) | 0(0) | 0(0) | 9(64.3) | 0(0) | 10(71.4) | 10(71.4) | 6(42.9) | 9(64.3) | 8(57.1) | 2(14.3) | |
Notes: Q1: Did the research questions and inclusion criteria for the review include the components of PICO? Q2: Did the report of the review contain an explicit statement that the review methods were established prior to the conduct of the review and did the report justify any significant deviations from the protocol? Q3: Did the review authors explain their selection of the study designs for inclusion in the review? Q4: Did the review authors use a comprehensive literature search strategy? Q5: Did the review authors perform study selection in duplicate? Q6: Did the review authors perform data extraction in duplicate? Q7: Did the review authors provide a list of excluded studies and justify the exclusions? Q8: Did the review authors describe the included studies in adequate detail? Q9: Did the review authors use a satisfactory technique for assessing the risk of bias (RoB) in individual studies that were included in the review? Q10: Did the review authors report on the sources of funding for the studies included in the review? Q11: If meta-analysis was performed did the review authors use appropriate methods for statistical combination of results? Q12: If meta-analysis was performed, did the review authors assess the potential impact of RoB in individual studies on the results of the meta-analysis or other evidence synthesis? Q13: Did the review authors account for RoB in individual studies when interpreting/discussing the results of the review? Q14: Did the review authors provide a satisfactory explanation for, and discussion of, any heterogeneity observed in the results of the review? Q15: If they performed quantitative synthesis did the review authors carry out an adequate investigation of publication bias (small study bias) and discuss its likely impact on the results of the review? Q16: Did the review authors report any potential sources of conflict of interest, including any funding they received for conducting the review?.
Abbreviations: Y, yes; PY, partial yes; N, no.
GRADE Quality Grading of 14 SRs and MAs of Acupuncture for KOA
| Author(Year) | Outcomes (n) | Limitations | Inconsistency | Indirectness | Imprecision | Publication Bias | Quality of Evidence |
|---|---|---|---|---|---|---|---|
| Chai (2009) | Apparent rate (4) | −1① | 0 | 0 | 0 | −1⑤ | Low |
| WOMAC score (2) | −1① | 0 | 0 | 0 | −1⑤ | Low | |
| WOMAC pain scores (2) | −1① | 0 | 0 | 0 | −1⑤ | Low | |
| WOMAC stiffness score (2) | −1① | 0 | 0 | 0 | −1⑤ | Low | |
| WOMAC daily activity score (2) | −1① | 0 | 0 | 0 | −1⑤ | Low | |
| Cao (2012) | AT versus SA for pain and function, short-term (10) | −1① | −1② | 0 | 0 | −1⑤ | Very Low |
| AT versus SA for pain and function, long-term (4) | −1① | 0 | 0 | −1③ | −1⑤ | Very Low | |
| AT versus UC for pain and function, short-term (6) | −1① | −1② | 0 | 0 | −1⑤ | Very Low | |
| AT versus UC for pain and function, long-term (4) | −1① | 0 | 0 | −1③ | −1⑤ | Very Low | |
| AT versus WS for pain and function, short-term (5) | −1① | −1② | 0 | 0 | −1⑤ | Very Low | |
| Lu (2012) | Total efficacy rate (10) | −1① | 0 | 0 | 0 | −1④ | Low |
| Lu (2015) | Short-term total efficacy rate (8) | −1① | −1② | 0 | 0 | 0 | Low |
| Long-term total efficacy rate (2) | −1① | 0 | 0 | 0 | 0 | Moderate | |
| Short-term cure rate (4) | −1① | 0 | 0 | 0 | 0 | Moderate | |
| Adverse effect (2) | −1① | 0 | 0 | 0 | 0 | Moderate | |
| Lin (2016) | Short-term WOMAC physical function scores (10) | −1① | −2② | 0 | −1③ | 0 | Very Low |
| Long-term WOMAC physical function scores (5) | −1① | −2② | 0 | 0 | 0 | Very Low | |
| Short-term WOMAC pain scores (11) | −1① | −2② | 0 | −1③ | 0 | Very Low | |
| Long-term WOMAC pain scores (5) | −1① | −2② | 0 | −1③ | 0 | Very Low | |
| Zhao (2016) | Efficacy rate (13) | −1① | 0 | 0 | 0 | −1⑤ | Low |
| Adverse effect (1) | −1① | 0 | 0 | 0 | −1⑤ | Low | |
| Hu (2016) | Efficacy rate (8) | −1① | 0 | 0 | 0 | −1⑤ | Low |
| WOMAC score (2) | −1① | −1② | 0 | 0 | −1⑤ | Very Low | |
| Guo (2018) | Total efficacy rate (11) | −1① | 0 | 0 | 0 | −1④ | Low |
| WOMAC score (2) | −1① | −2② | 0 | −1③ | −1④ | Very Low | |
| Cao (2019) | Short-term efficacy rate (9) | −1① | 0 | 0 | 0 | 0 | Moderate |
| Kong (2019) | Efficacy rate (16) | −1① | 0 | 0 | 0 | −1④ | Low |
| VAS score (14) | −1① | −2② | 0 | 0 | −1⑤ | Very Low | |
| Lysholm knee score (11) | −1① | −2② | 0 | 0 | −1⑤ | Very Low | |
| WOMAC score (5) | −1① | −2② | 0 | 0 | −1⑤ | Very Low | |
| Zheng (2020) | Efficacy rate (8) | −1① | 0 | 0 | 0 | −1⑤ | Low |
| VAS score (7) | −1① | −2② | 0 | 0 | −1⑤ | Very Low | |
| Lysholm knee score (7) | −1① | −2② | 0 | 0 | −1⑤ | Very Low | |
| Wang (2020) | AT versus NA for pain reduction (11) | −1① | −2② | 0 | −1③ | 0 | Very Low |
| AT versus NA for physical function improvement (10) | −1① | −2② | 0 | −1③ | 0 | Very Low | |
| AT versus SA for pain reduction (12) | −1① | −2② | 0 | −1③ | 0 | Very Low | |
| AT versus SA for physical function improvement (12) | −1① | −2② | 0 | −1③ | 0 | Very Low | |
| Fan (2020) | Total efficacy rate (19) | −1① | 0 | 0 | 0 | −1④ | Very Low |
| Lysholm knee score (4) | −1① | −2② | 0 | 0 | −1④ | Very Low | |
| VAS score (11) | −1① | −2② | 0 | 0 | −1④ | Very Low | |
| WOMAC score (16) | −1① | −2② | 0 | 0 | −1④ | Very Low | |
| Adverse effect (8) | −1① | 0 | 0 | −1③ | −1④ | Very Low | |
| Yang (2021) | total efficacy rate (10) | −1① | 0 | 0 | −1③ | 0 | Low |
| Short-term cure rate (10) | −1① | 0 | 0 | −1③ | 0 | Low | |
| Adverse effect (1) | −1① | 0 | 0 | −1① | 0 | Low | |
| JOA score (3) | −1① | 0 | 0 | −1③ | 0 | Low |
Notes: ①The design of the experiment with a large bias in random, distributive hiding or blind; ②The confidence interval overlaps less, the heterogeneity test P is very small, and the I is larger; ③Confidence interval is not narrow enough; ④Funnel graph asymmetry; ⑤Fewer studies are included and there may be greater publication bias.
Abbreviations: AT, acupuncture therapy; NA, no acupuncture; SA, sham acupuncture; UC, usual care; WS, waiting list; WOMAC, Western Ontario and Mcmaster Universities Arthritis Index; VAS, Visual Analog Scale; JOA, Japanese Orthopaedic Association.
Tabular Presentation of Risk of Bias of Included SRs/MAs
| Review | Phase 2 | Phase 3 | |||
|---|---|---|---|---|---|
| 1. Study Eligibility Criteria | 2. Identification and Selection of Studies | 3. Data Collection and Study Appraisal | 4.Synthesis and Findings | Risk of Bias in the Review | |
| Chai (2009) | |||||
| Cao (2012) | |||||
| Lu (2012) | |||||
| Lu (2015) | |||||
| Lin (2016) | |||||
| Zhao (2016) | |||||
| Hu (2016) | |||||
| Guo (2018) | |||||
| Cao (2019) | |||||
| Kong (2019) | |||||
| Zheng (2020) | |||||
| Wang (2020) | |||||
| Fan (2020) | |||||
| Yang (2021) | |||||
Abbreviations: , low risk of bias; , high risk of bias; ?, unclear.
Figure 2Graphical presentation of risk of bias of included SRs and MAs.